MDMichael M. Danziger

Michael M. Danziger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael M. Danziger has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Alzheimer’s disease target and drug discovery by leveraging multiomics and electronic health data

    by Yuan Hou, Yichen Li, Pengyue Zhang, Noah Lorincz-Comi, Dhruv Gohel, Fan Fan, Yunguang Qiu, Jun Yang, Xin Chen, Wenqiang Song, et al.

    Despite prolific genomic data from individuals with Alzheimer’s disease (AD), translation into treatments has lagged. Here we applied Mendelian randomization to multiple AD genome-wide association studies and functional multiomics datasets to nominate druggable targets, identifying 19 targets for individuals of European ancestry and 7 for African ancestry. This included epoxide hydrolase 2 (EPHX2), for which we identified a protective missense variant (p.Arg287Gln). Experiments in induced pluripotent stem cell-derived neurons and cerebral organoids from patients with AD validated the protective role of p.Arg287Gln via reduced levels of EPHX2 and phosphorylated tau (pTau-181). Pharmacological inhibition of EPHX2 improved cognitive performance in the 5xFAD mouse model of AD. Finally, by leveraging electronic health data from 111,680 patients with mild cognitive impairment, we identified 12 drugs associated with reduced AD incidence, including trazodone (targeting ADRA1A) and baclofen (targeting GABBR1). Thus, integrating multiomics data, functional validation and electronic health data identifies new approaches for treating AD.

  • Open Access

    Structural inequality shapes the daily rhythm of stationarity and mobility

    by Zihao Tian, Chao Zhang, Weiyu Li, Lixin Tian, Michael M. Danziger, Wenshan Liu, Qi R. Wang

  • Open Access

    Single‐microglia transcriptomic transition network‐based prediction and real‐world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease

    by Jielin Xu, Wenqiang Song, Zhenxing Xu, Michael M. Danziger, Ehud Karavani, Chengxi Zang, Xin Chen, Yichen Li, Isabela M Rivera Paz, Dhruv Gohel, et al.

    INTRODUCTION: High microglial heterogeneities hinder the development of microglia‐targeted treatment for Alzheimer's disease (AD). METHODS: We integrated 0.7 million single‐nuclei RNA‐sequencing transcriptomes from human brains using a variational autoencoder. We predicted AD‐relevant microglial subtype‐specific transition networks for disease‐associated microglia (DAM), tau microglia, and neuroinflammation‐like microglia (NIM). We prioritized drugs by specifically targeting microglia‐specific transition networks and validated drugs using two independent real‐world patient databases. RESULTS: We identified putative AD molecular drivers (e.g., SYK , CTSB , and INPP5D ) in transition networks of DAM and NIM. Via specifically targeting NIM, we identified that usage of ketorolac was associated with reduced AD incidence in both MarketScan (hazard ratio [HR] = 0.89) and INSIGHT (HR = 0.83) Clinical Research Network databases, mechanistically supported by ketorolac‐treated transcriptomic data from AD patient induced pluripotent stem cell–derived microglia. DISCUSSION: This study offers insights into the pathobiology of AD‐relevant microglial subtypes and identifies ketorolac as a potential anti‐inflammatory treatment for AD. Highlights: An integrative analysis of ≈ 0.7 million single‐nuclei RNA‐sequencing transcriptomes from human brains identified Alzheimer's disease (AD)–relevant microglia subtypes. Network‐based analysis identified putative molecular drivers (e.g., SYK, CTSB, INPP5D ) of transition networks between disease‐associated microglia (DAM) and neuroinflammation‐like microglia (NIM). Via network‐based prediction and population‐based validation, we identified that usage of ketorolac (a US Food and Drug Administration–approved anti‐inflammatory medicine) was associated with reduced AD incidence in two independent patient databases. Mechanistic observation showed that ketorolac treatment downregulated the Type‐I interferon signaling in patient induced pluripotent stem cell–derived microglia, mechanistically supporting its protective effects in real‐world patient databases.


  • Open Access

    Mastering percolation-like games with deep learning

    by Michael M. Danziger, Omkar R. Gojala, Sean P. Cornelius

    Though robustness of networks to random attacks has been widely studied, intentional destruction by an intelligent agent is not tractable with previous methods. Here we devise a single-player game on a lattice that mimics the logic of an attacker attempting to destroy a network. The objective of the game is to disable all nodes in the fewest number of steps. We develop a reinforcement learning approach using deep Q-learning that is capable of learning to play this game successfully, and in so doing, to optimally attack a network. Because the learning algorithm is universal, we train agents on different definitions of robustness and compare the learned strategies. We find that superficially similar definitions of robustness induce different strategies in the trained agent, implying that optimally attacking or defending a network is sensitive to the particular objective. Our method provides an approach to understand network robustness, with potential applications to other discrete processes in disordered systems.

  • Spreading of Failures in Interdependent Networks

    by Louis M. Shekhtman, Michael M. Danziger, Shlomo Havlin


  • Open Access

    Fragmentation of outage clusters during the recovery of power distribution grids

    by Hao Wu, Xiangyi Meng, Michael M. Danziger, Sean P. Cornelius, Hui Tian, Albert-László Barabási

    The understanding of recovery processes in power distribution grids is limited by the lack of realistic outage data, especially large-scale blackout datasets. By analyzing data from three electrical companies across the United States, we find that the recovery duration of an outage is connected with the downtime of its nearby outages and blackout intensity (defined as the peak number of outages during a blackout), but is independent of the number of customers affected. We present a cluster-based recovery framework to analytically characterize the dependence between outages, and interpret the dominant role blackout intensity plays in recovery. The recovery of blackouts is not random and has a universal pattern that is independent of the disruption cause, the post-disaster network structure, and the detailed repair strategy. Our study reveals that suppressing blackout intensity is a promising way to speed up restoration.


  • Top Cited Papers
    Open Access

    Recovery coupling in multilayer networks

    by Michael M. Danziger, Albert-László Barabási

    The increased complexity of infrastructure systems has resulted in critical interdependencies between multiple networks—communication systems require electricity, while the normal functioning of the power grid relies on communication systems. These interdependencies have inspired an extensive literature on coupled multilayer networks, assuming a hard interdependence, where a component failure in one network causes failures in the other network, resulting in a cascade of failures across multiple systems. While empirical evidence of such hard failures is limited, the repair and recovery of a network requires resources typically supplied by other networks, resulting in documented interdependencies induced by the recovery process. In this work, we explore recovery coupling, capturing the dependence of the recovery of one system on the instantaneous functional state of another system. If the support networks are not functional, recovery will be slowed. Here we collected data on the recovery time of millions of power grid failures, finding evidence of universal nonlinear behavior in recovery following large perturbations. We develop a theoretical framework to address recovery coupling, predicting quantitative signatures different from the multilayer cascading failures. We then rely on controlled natural experiments to separate the role of recovery coupling from other effects like resource limitations, offering direct evidence of how recovery coupling affects a system’s functionality.


  • Faster calculation of the percolation correlation length on spatial networks

    by Michael M. Danziger, Bnaya Gross, Sergey V. Buldyrev

    The divergence of the correlation length xi at criticality is an important phenomenon of percolation in two-dimensional systems. Substantial speed-ups to the calculation of the percolation threshold and component distribution have been achieved by utilizing disjoint sets, but existing algorithms of this sort cannot measure the correlation length. Here we utilize the parallel axis theorem to track the correlation length as nodes are added to the system, allowing us to utilize disjoint sets to measure xi for the entire percolation process with arbitrary precision in a single sweep. This algorithm enables direct measurement of the correlation length in lattices as well as spatial network topologies and provides an important tool for understanding critical phenomena in spatial systems.


  • Top Cited Papers

    Dynamic interdependence and competition in multilayer networks

    by Michael M. Danziger, Ivan Bonamassa, Stefano Boccaletti, Shlomo Havlin


  • Open Access

    Critical field-exponents for secure message-passing in modular networks

    by Louis M Shekhtman, Michael M Danziger, Ivan Bonamassa, Sergey V. Buldyrev, Guido Caldarelli, Vinko Zlatić, Shlomo Havlin